Drug Safety Information for DEPACON (Valproate sodium)

FDA Safety-related Labeling Changes for DEPACON (VALPROATE SODIUM) Brand name discontinued; available as generic: Safety Information Link

Adverse Drug Reactions for DEPACON* (Valproate sodium)

These charts and graphs are based on reports received through the FDA Adverse Event Reporting System (FAERS) program (see below).

Top 20 Adverse Effects Associated with DEPACON
(reported in FDA Medwatch/FAERS Reports)

  Side Effect # of FDA Reports
1Convulsion1008
2Drug interaction705
3Pyrexia461
4Toxicity to various agents459
5Somnolence*405
6Epilepsy375
7Foetal anticonvulsant syndrome337
8Drug ineffective335
9Vomiting335
10Malaise306
11Confusional state305
12Condition aggravated278
13Tremor276
14Diarrhoea272
15Nausea252
16Overdose250
17Neutropenia245
18Fatigue235
19Fall235
20Pneumonia232

* This side effect also appears in "Top 10 Side Effects of DEPACON " in the drug's Review Summary based on AskaPatient reviews.

Top 10 Reasons for Taking DEPACON
(associated with FDA Medwatch/FAERS Reports)

Reason # of FDA Reports
1Epilepsy6323
2Product used for unknown indication5339
3Maternal exposure during pregnancy2450
4Convulsion2426
5Affective disorder1147
6Bipolar disorder*1050
7Maternal exposure timing unspecified609
8Schizophrenia469
9Mood altered460
10Depression*330

*Also a top-10 reason in AskaPatient Review Summary.


Types of Adverse Events for DEPACON

Total Reports Filed with FDA: 46153


Number of FDA Adverse Event Reports by Patient Age for DEPACON

Total Reports Filed with FDA: 46153*


* Reports for drugs with the same active ingredients have been aggregated in this analysis: Valproate sodium (Epilim, Divaproex, Depacon, Valproate sodium)

Charts are based on 46153 reports filed with the FDA between 2004 and June 2015.

Adverse Event Reports are submitted to the FDA by pharmaceutical companies (mandatory reporting is required by manufacturers, distributors, or importers), health care providers such as doctors (voluntary reporting), and by patients themselves (voluntary reporting). More Information on FDA MedWatch (FDA Safety Information and Adverse Event Reporting Program)Voluntary reporting takes place under the FDA's MedWatch program, where health care professionals and consumers submit reports to FDA when they find a problem with a drug, medical device, biologic, or other FDA-regulated product. An adverse event is any undesirable experience or extreme side effect associated with the use of a medical product. Adverse events include: death, life threatening event, hospitalization, disability or permanent damage, congenital anomaly or birth defect, medical product use requiring a surgical or other intervention, or other serious medical situation believed to be caused by the drug.

Click to go back to search results and DEPACON Reviews and Review Summary .

Historical Analytics of FDA Adverse Event Reports Provided by Druginformer.com. FDA Drug Safety Information, including safety-related labeling updates, required post-approval safety studies, risk evaluation management strategies (REMS), alerts, and recalls are compiled by AskaPatient.com from the U.S. Food and Drug Administration.